Accuray Incorporated (NASDAQ: ARAY) announced today that 5D Clinics has treated the first patients in the city of Melbourne, ...
For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...
For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...
For patients with intermediate-risk localized prostate cancer, stereotactic body radiation therapy (SBRT) yields favorable bowel health-related quality of life (HRQOL).
A phase 2 trial tested the efficacy of local stereotactic body radiation therapy (SBRT) use after radical prostatectomy.
For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...
Researchers report longer progression-free survival when Lutetium-177 was combined with standard radiotherapy for limited ...
Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for ...
SAN FRANCISCO, Sept. 26, 2025 ― Researchers from The University of Texas MD Anderson Cancer Center will present new data at ...
Despite SBRT (radiation) to oligometastatic sites, prostate cancer progression still occurs in a majority of patients due to occult microscopic disease.